The data to be presented encompasses five of the company’s novel drug candidates: BCR-ABL tyrosine kinase inhibitor olverembatinib (HQP1351), Bcl-2 inhibitor lisaftoclax (APG-2575), FAK/ALK/ROS1 ...

One poster demonstrating cell-free DNA molecular response as a potential surrogate endpoint to measure clinical efficacy of azenosertib in ...

DelveInsight's "ROCKLATAN/ROCLANDA Market Size, Forecast, and Market Insight Report" highlights the details around ...

Shares of Inovio Pharmaceuticals Inc. INO slid 3.72% to $1.81 Tuesday, on what proved to be an all-around positive trading ...

Shares of West Pharmaceutical Services Inc. WST slid 2.63% to $225.80 Tuesday, on what proved to be an all-around favorable ...

Cloudflare stock faces challenges with high valuations, slowing growth, and profit concerns. Click here to read an analysis ...

Novo Nordisk is taking aim at Eli Lilly with a new obesity drug deal. Meanwhile, a survey shows doctors’ perception of the ...

Bernard Fontana, France's nominee to head state nuclear company EDF, would face a daunting to-do list if he gets the job, ...

After every meal, the intestines perform an action called peristalsis - moving food through their hollow interiors with coordinated contractions and relaxations of the smooth muscle.

Merck has signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion, ...

(Reuters) - Schneider Electric said on Tuesday it plans to invest over $700 million in its U.S. operations over the next two ...

Cooper Flagg #2 of the Duke Blue Devils defends Jason Asemota #5 of the Baylor Bears during the second round of the 2025 NCAA ...